Aurinia Pharmaceuticals

YTD

ALL

Trade Aurinia Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

CEO

Peter S. Greenleaf

CEOPeter S. Greenleaf

Employees

130

Employees130

Headquarters

Edmonton, Alberta

HeadquartersEdmonton, Alberta

Founded

1993

Founded1993

Employees

130

Employees130

AUPH Key Statistics

Market cap

1.07B

Market cap1.07B

Price-Earnings ratio

29.40

Price-Earnings ratio29.40

Dividend yield

—

Dividend yield—

Average volume

1.17M

Average volume1.17M

High today

$8.49

High today$8.49

Low today

$7.80

Low today$7.80

Open price

$8.18

Open price$8.18

Volume

1.83M

Volume1.83M

52 Week high

$10.67

52 Week high$10.67

52 Week low

$5.08

52 Week low$5.08

AUPH News

TipRanks 1d

Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges

Aurinia Pharmaceuticals ((AUPH)) has held its Q1 earnings call. Read on for the main highlights of the call. Protect Your Portfolio Against Market Uncertainty...

TipRanks 2d

Aurinia Pharmaceuticals Reports Strong Q1 2025 Financial Results and Positive Outlook

Aurinia Pharmaceuticals ( (AUPH) ) has issued an announcement. Aurinia Pharmaceuticals reported a strong financial performance for the first quarter of 2025, w...

Simply Wall St 5d

Aurinia Pharmaceuticals Inc.'s CEO Will Probably Find It Hard To See A Huge Raise This Year

Advertisement Key Insights Aurinia Pharmaceuticals to hold its Annual General Meeting on 15th of May CEO Peter Greenleaf's total compensation includes salary...

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own AUPH. This list is generated using Robinhood data, and it’s not a recommendation.